Injectable Bioactive Composites vs RMGI for Proximal Cavities in Primary Molars
GIOMER-RCT
Clinical Evaluation of Injectable Bioactive Composites Versus Resin Modified Glass Ionomer for Restoring Proximal Cavities in Primary Molars: A Randomized Clinical Tria
1 other identifier
interventional
50
0 countries
N/A
Brief Summary
This randomized clinical trial aims to evaluate and compare the clinical performance of injectable bioactive composite (Beautifil Flow Plus X, Shofu) versus Resin Modified Glass Ionomer (RMGI) in restoring proximal cavities (Class II) in primary molars of children aged 3-8 years over a 12-month follow-up period, using revised FDI criteria.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 18, 2026
CompletedFirst Posted
Study publicly available on registry
May 1, 2026
CompletedStudy Start
First participant enrolled
May 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2027
May 1, 2026
April 1, 2026
1.1 years
February 18, 2026
April 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Secondary Caries
Assessed using revised FDI criteria (B1: caries at restoration margin). Evaluated by visual examination and short air drying. Scored on ordinal scale 1-5.
Baseline, 3, 6, and 12 months
Secondary Outcomes (5)
Postoperative sensitivity / pulp status
Baseline, 3, 6, and 12 months
Marginal Adaptation
Baseline, 3, 6, and 12 months
Proximal Contact Point
Baseline, 3, 6, and 12 months
Occlusal Wear
Baseline, 3, 6, and 12 months
Fracture and Retention
Baseline, 3, 6, and 12 months
Study Arms (2)
RMGIC
ACTIVE COMPARATORcavity restorations in primary molars using a resin-modified glass ionomer cement. Following standard cavity preparation, the RMGI material will be placed according to the manufacturer's instructions. Clinical performance will be evaluated over the follow-up period in terms of restoration retention, marginal adaptation, secondary caries, postoperative sensitivity, and overall clinical success.
giomer
EXPERIMENTALrestoration of proximal cavities in primary molars using an injectable bioactive composite (Giomer) material. Cavities will be prepared following minimally invasive principles, isolated appropriately, and restored according to the manufacturer's instructions using adhesive bonding. Clinical performance will be evaluated in terms of retention, marginal adaptation, secondary caries, postoperative sensitivity, and overall restoration success during the follow-up period.
Interventions
restoration of proximal cavities in primary molars using an injectable bioactive composite (Giomer) material. Cavities will be prepared following minimally invasive principles, isolated appropriately, and restored according to the manufacturer's instructions using adhesive bonding. Clinical performance will be evaluated in terms of retention, marginal adaptation, secondary caries, postoperative sensitivity, and overall restoration success during the follow-up period.
Resin-Modified Glass Ionomer (RMGI) is a fluoride-releasing restorative material used for the restoration of carious primary teeth. It combines the properties of conventional glass ionomer cement with resin components to improve mechanical strength, adhesion, and moisture tolerance. In this study, RMGI will be used for restoring cavitated carious lesions in primary teeth following caries removal according to minimally invasive dentistry principles.
Eligibility Criteria
You may qualify if:
- Children aged 3-8 years of both genders
- Cooperative behavior manageable by operators
- Willing to sign informed consent
- Accepts the follow-up period
- Moderate to low caries risk according to Cariogram application
- Posterior primary molar with proximal carious lesion (ICDAS 3 or 4) with no signs or symptoms of pulpal involvement
- Radiographically extending to outer 1/3 of dentin
You may not qualify if:
- Allergy to any restorative materials
- Patients undergoing orthodontic treatment with fixed appliances
- Patients with debilitating systemic diseases
- Children with special needs
- Teeth with previous restorations
- Periapical radiolucencies or sensitivity to percussion
- Mobile teeth
- External or internal resorption
- Cervical carious lesions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nadine Elshayal
Cairo University
- PRINCIPAL INVESTIGATOR
Dina Ez Mohamed
Cairo University
- STUDY DIRECTOR
Osama Elshahawy
Cairo University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Blinding of operators, patients, parents and outcome assessors was not possible as both materials differ in appearance and application technique.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Master's Student
Study Record Dates
First Submitted
February 18, 2026
First Posted
May 1, 2026
Study Start
May 1, 2026
Primary Completion (Estimated)
June 1, 2027
Study Completion (Estimated)
September 1, 2027
Last Updated
May 1, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share